Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: captopril / codeine attending: chief complaint: s/p carotid stent placement major surgical or invasive procedure: carotid stent placement by dr. history of present illness: 76yo m pmhx copd, cad s/p s/p pci rca , s/p unsuccessful pci of the rca and om , s/p left renal artery stenting, recently found to have critical 80-90% stenosis in the on carotid artery duplex, now s/p stenting. several weeks prior to presentation pt found to have hollenhorst plaque of r eye on routine ophthalmology visit, subsequently found to have above carotid finding. patient was asymptomatic at that time w only complaint being possible increased blurriness of r eye on top of chronic glaucoma symptoms (legally blind). . on day of admission, patient underwent stenting without known complication, was hemodynamically stable and was admitted to ccu for further monitoring. . on review of symptoms, patient reports chronic bilateral le numbness, chronic visual deficits glaucoma, and unchanged chronic doe copd. past medical history: 1. cardiac risk factors: - diabetes, + dyslipidemia, + hypertension 2. cardiac history: - percutaneous coronary interventions: rca pci ; failed pci of rca and lcx . - stenosis 80%, now s/p stenting - cad, s/p mi, s/p pci 3. other past medical history: - copd (not on home o2) - chronic pain syndrome - s/p left renal artery stenting - chronic back pain - lumbar disc disease osteoporosis - abdominal aortic aneurysm - pulmonary nodule - peptic ulcer disease - glaucoma - s/p hemorrhoidectomy - s/p l inguinal hernia repair - s/p appendectomy - s/p tonsillectomy social history: lives at home with wife in , has 3 adult children. uses a cane for ambulation. current smoker, >120pack-years, rare etoh, denies illicits family history: mother died of gastric cancer at age 83 years of age. father died of alcoholism at age 55. physical exam: admission physical exam: . vs: normal and stable general: nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. perrl, eomi. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: supple with jvp of *** cm. cardiac: pmi located in 5th intercostal space, midclavicular line. rr, normal s1, s2. no m/r/g. no thrills, lifts. no s3 or s4. lungs: no chest wall deformities, scoliosis or kyphosis. resp were unlabored, no accessory muscle use. ctab, no crackles, wheezes or rhonchi. abdomen: soft, ntnd. no hsm or tenderness. abd aorta not enlarged by palpation. no abdominial bruits. extremities: no c/c/e. no femoral bruits. skin: no stasis dermatitis, ulcers, scars, or xanthomas. pulses: right: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ left: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ . discharge physical exam: . vs: normal and stable general: nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. perrl, eomi. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: supple with jvp of *** cm. cardiac: pmi located in 5th intercostal space, midclavicular line. rr, normal s1, s2. no m/r/g. no thrills, lifts. no s3 or s4. lungs: no chest wall deformities, scoliosis or kyphosis. resp were unlabored, no accessory muscle use. ctab, no crackles, wheezes or rhonchi. abdomen: soft, ntnd. no hsm or tenderness. abd aorta not enlarged by palpation. no abdominial bruits. extremities: no c/c/e. no femoral bruits. skin: no stasis dermatitis, ulcers, scars, or xanthomas. neuro: cn's iii-xii intact, 5/5 strength in all 4 extremities, no gross sensory deficits, 2+ reflexes throughout. pulses right: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ left: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ pertinent results: admission labs: . 03:14pm blood wbc-7.4 rbc-4.32* hgb-13.5* hct-39.0* mcv-90 mch-31.2 mchc-34.5 rdw-12.7 plt ct-182 03:14pm blood neuts-60.8 lymphs-32.1 monos-4.4 eos-2.2 baso-0.5 03:14pm blood pt-12.4 ptt-33.0 inr(pt)-1.0 03:14pm blood glucose-107* urean-23* creat-1.3* na-137 k-4.2 cl-103 hco3-23 angap-15 03:14pm blood calcium-8.8 phos-3.6 mg-2.0 . pertinent labs: . 03:14pm blood ck-mb-2 03:22am blood ck-mb-3 . discharge labs: . 03:22am blood wbc-8.3 rbc-4.24* hgb-13.1* hct-38.6* mcv-91 mch-30.9 mchc-34.0 rdw-12.2 plt ct-196 03:22am blood plt ct-196 03:22am blood glucose-115* urean-22* creat-1.3* na-139 k-4.1 cl-103 hco3-25 angap-15 03:22am blood calcium-9.4 phos-3.2 mg-2.0 . micro/path: mrsa screen : negative . imaging/studies: . c.cath : final diagnosis: 1. aortic arch angiography showed type 2 arch with moderate calcification. 2. no significant disease in the right and left common carotids or subclavian arteries. 3. right carotid angiography showed 90% ulcerated and eccentric stenosis in the proximal right internal carotid artery sparing the ostium. kink in the vessel distal to the stenosis. rest of the is widely patent supplying both aca and mca. 4. left cca and ica are widely patent. 5. the aforementioned 90% stenosis was successfully treated with pta and stenting with a 8.0 x 30 mm xact stent. the procedure was performed using distal protection ( embolic protection device). . complete carotid series : impression: there is no evidence of significant carotid artery stenosis bilaterally. brief hospital course: 76yo pmhx cad, htn, hld, recently found to have critical stenosis now s/p today without complication, admitted for post-procedure monitoring. . active diagnoses: . #right internal carotid artery stent placement: mr. presented with 80-90% stenosis of , and underwent catheterization with stenting without known complications. there was, however, question of kinking of distal end of stent which led the team to obtain a carotid duplex study which was normal. he was started on a nitro drip to maintain his systolic pressures in the 100-130 mmhg range but never actually required the medication. he was found to be completely neurologically intact with baseline poor vision related to his glaucoma and was discharge on his home aspirin and plavix with follow-up appointments arranged. . # coronary artery disease: his home atenolol and isosorbide were held given concerns for his blood pressure in the post-stent period with follow-up established with his outpatient cardiologist for re-initiation of those medications. he was continued on his home asa, plavix, and ezetimibe-simvastatin. he had ck-mb negative x 2 during this admission. . chronic diagnoses: . # copd: stable. he was continued on his albuterol nebs and home advair. . # glaucoma: stable with very poor baseline vision. he was continued on his home eye drops. . # osteoporosis: stable. continued on his home calcitonin, calcium, and vitamin d3. . # chronic pain: stable. continued on his home percocet. . # bph: stable. we attempted to hold his tamsulosin given concern for hypotension but he had significant symptoms and robust blood pressures so this medications was continued. . transitional issues: #he was discharged with close follow-up medications on admission: - albuterol sulfate nebs q6-8hrs - atenolol 100mg daily - bimatoprost 0.03 % 1 drop qhs - brimonidine 0.2 % 1 drop - calcitonin - plavix 75 mg daily - ezetimibe-simvastatin 10 mg-10 mg qhs - advair 500 mcg-50 mcg - isosorbide dinitrate 40mg tid - slntg prn - percocet 5mg-325mg 1-2 tabs q4hrs prn - tamsulosin 0.4 mg capsule qhs - asa 325mg daily - calcium / vitamin d discharge medications: 1. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) neb inhalation q4h (every 4 hours) as needed for shortness of breath or wheezing. 2. lumigan 0.03 % drops sig: one (1) ophthalmic qhs (once a day (at bedtime)). 3. brimonidine 0.15 % drops sig: one (1) drop ophthalmic q12h (every 12 hours). 4. calcitonin (salmon) 200 unit/actuation spray, non-aerosol sig: one (1) nasal daily (daily). 5. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). 6. ezetimibe-simvastatin 10-10 mg tablet sig: one (1) tablet po once a day. 7. fluticasone-salmeterol 500-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 8. tamsulosin 0.4 mg capsule, ext release 24 hr sig: one (1) capsule, ext release 24 hr po hs (at bedtime). 9. percocet 5-325 mg tablet sig: 1-2 tablets po every four (4) hours as needed for pain. 10. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 11. calcium 500 + d oral discharge disposition: home discharge diagnosis: primary carotid stenosis discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - requires assistance or aid (walker or cane). discharge instructions: mr. -- . it was a pleasure taking care of you at . you were admitted for carotid stenting--a procedure to help open up one of the arteries that supplies your brain with blood. you were monitored after your procedure and are now ready for discharge. . during your hospitalization, the following changes were made to your medications: - held atenolol - held isosorbide dinitrate . please talk to your cardiologist dr. before you restart either of these medications. please make sure to continue taking your aspirin and plavix every day. . see below for the follow-up you have scheduled with dr. and dr. . followup instructions: 1) dr. @ cardiology, @ 09:30am, 2) dr. @ cardiology, @ 10:30am procedure: arteriography of cerebral arteries aortography percutaneous angioplasty of extracranial vessel(s) percutaneous insertion of carotid artery stent(s) cranial or peripheral nerve graft insertion of one vascular stent procedure on single vessel diagnoses: coronary atherosclerosis of native coronary artery unspecified glaucoma hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) percutaneous transluminal coronary angioplasty status occlusion and stenosis of carotid artery without mention of cerebral infarction osteoporosis, unspecified other emphysema other diseases of lung, not elsewhere classified abdominal aneurysm without mention of rupture other and unspecified disc disorder, lumbar region examination of participant in clinical trial legal blindness, as defined in u.s.a. chronic pain syndrome 

Answer: The patient is high likely exposed to